Market Closed -
Nasdaq Stockholm
06:59:50 2024-05-08 am EDT
|
5-day change
|
1st Jan Change
|
32.5
SEK
|
-1.37%
|
|
+7.26%
|
+9.80%
|
Fiscal Period: December |
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
3,018
|
1,017
|
1,215
|
1,449
|
-
|
-
|
Enterprise Value (EV)
1 |
3,143
|
1,017
|
1,492
|
1,702
|
1,632
|
1,588
|
P/E ratio
|
388
x
|
-122
x
|
133
x
|
48.1
x
|
23.1
x
|
18.8
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
17.4
x
|
3.61
x
|
3.66
x
|
3.95
x
|
3.48
x
|
3.09
x
|
EV / Revenue
|
18.1
x
|
3.61
x
|
4.5
x
|
4.64
x
|
3.92
x
|
3.39
x
|
EV / EBITDA
|
54.1
x
|
12.4
x
|
15.4
x
|
16.1
x
|
12.3
x
|
10.2
x
|
EV / FCF
|
-31.8
x
|
-
|
-34.3
x
|
54.9
x
|
22.8
x
|
18
x
|
FCF Yield
|
-3.15%
|
-
|
-2.92%
|
1.82%
|
4.39%
|
5.56%
|
Price to Book
|
7.59
x
|
-
|
2.29
x
|
2.12
x
|
1.95
x
|
1.76
x
|
Nbr of stocks (in thousands)
|
389,191
|
416,173
|
457,118
|
522,421
|
-
|
-
|
Reference price
2 |
7.755
|
2.443
|
2.658
|
2.774
|
2.774
|
2.774
|
Announcement Date
|
3/10/22
|
3/8/23
|
2/15/24
|
-
|
-
|
-
|
Fiscal Period: December |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
-
|
173.4
|
281.3
|
331.7
|
366.7
|
416.6
|
469
|
EBITDA
1 |
-
|
58.11
|
81.91
|
97.15
|
105.8
|
132.4
|
155.1
|
EBIT
1 |
-
|
41.42
|
54.68
|
65.11
|
72.4
|
97.02
|
118.2
|
Operating Margin
|
-
|
23.9%
|
19.44%
|
19.63%
|
19.74%
|
23.29%
|
25.21%
|
Earnings before Tax (EBT)
1 |
-
|
12.76
|
0.924
|
19.45
|
39.07
|
80.7
|
103.8
|
Net income
1 |
52.79
|
6.586
|
-6.742
|
9.84
|
28.4
|
60.41
|
68.43
|
Net margin
|
-
|
3.8%
|
-2.4%
|
2.97%
|
7.74%
|
14.5%
|
14.59%
|
EPS
2 |
0.1800
|
0.0200
|
-0.0200
|
0.0200
|
0.0577
|
0.1199
|
0.1472
|
Free Cash Flow
1 |
-
|
-98.98
|
-
|
-43.48
|
31
|
71.67
|
88.33
|
FCF margin
|
-
|
-57.1%
|
-
|
-13.11%
|
8.45%
|
17.2%
|
18.84%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
29.31%
|
54.12%
|
56.96%
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
109.17%
|
118.64%
|
129.08%
|
Dividend per Share
2 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
6/9/21
|
3/10/22
|
3/8/23
|
2/15/24
|
-
|
-
|
-
|
Fiscal Period: December |
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
2025 Q2
|
---|
Net sales
1 |
48.7
|
67.94
|
67.03
|
70.88
|
75.46
|
88.1
|
81.31
|
79.88
|
82.46
|
91.3
|
91.4
|
90.8
|
93.2
|
101.4
|
101.4
|
EBITDA
1 |
13.18
|
22.13
|
19.91
|
19.22
|
20.64
|
28.23
|
22.75
|
20.73
|
25.44
|
26.68
|
26.6
|
26.3
|
28.8
|
31.58
|
31.58
|
EBIT
1 |
8.713
|
15.9
|
13.62
|
8.826
|
12.72
|
21.16
|
14.47
|
12.51
|
16.96
|
18.49
|
18.3
|
-
|
-
|
23.96
|
23.96
|
Operating Margin
|
17.89%
|
23.41%
|
20.32%
|
12.45%
|
16.86%
|
24.02%
|
17.8%
|
15.67%
|
20.57%
|
20.25%
|
20.02%
|
-
|
-
|
23.63%
|
23.63%
|
Earnings before Tax (EBT)
1 |
1.892
|
8.911
|
11.1
|
-0.627
|
-18.46
|
9.085
|
6.92
|
9.8
|
-6.357
|
5.466
|
10.3
|
10
|
12.5
|
-
|
-
|
Net income
1 |
2.024
|
5.424
|
9.992
|
-1.618
|
-20.54
|
5.405
|
2.994
|
7.432
|
-6.458
|
3.502
|
7.3
|
7
|
8.8
|
-
|
-
|
Net margin
|
4.16%
|
7.98%
|
14.91%
|
-2.28%
|
-27.22%
|
6.14%
|
3.68%
|
9.3%
|
-7.83%
|
3.84%
|
7.99%
|
7.71%
|
9.44%
|
-
|
-
|
EPS
2 |
0.0100
|
0.0100
|
0.0300
|
-
|
-0.0500
|
0.0100
|
0.0100
|
0.0200
|
-0.0100
|
0.0100
|
0.0100
|
-
|
-
|
0.0257
|
0.0257
|
Dividend per Share
2 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
3/10/22
|
5/24/22
|
8/24/22
|
11/16/22
|
3/8/23
|
5/4/23
|
8/17/23
|
11/8/23
|
2/15/24
|
5/2/24
|
-
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
-
|
125
|
-
|
276
|
254
|
183
|
139
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
2.155
x
|
-
|
2.844
x
|
2.397
x
|
1.38
x
|
0.8963
x
|
Free Cash Flow
1 |
-
|
-99
|
-
|
-43.5
|
31
|
71.7
|
88.3
|
ROE (net income / shareholders' equity)
|
-
|
6.41%
|
-
|
4.5%
|
5.09%
|
8.01%
|
8.71%
|
ROA (Net income/ Total Assets)
|
-
|
3.43%
|
-
|
2.39%
|
2.55%
|
4.88%
|
5.87%
|
Assets
1 |
-
|
192.2
|
-
|
411.3
|
1,113
|
1,238
|
1,167
|
Book Value Per Share
2 |
-
|
1.020
|
-
|
1.160
|
1.310
|
1.420
|
1.580
|
Cash Flow per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capex
1 |
-
|
5.41
|
-
|
14.9
|
13.2
|
14.5
|
17.1
|
Capex / Sales
|
-
|
3.12%
|
-
|
4.49%
|
3.6%
|
3.49%
|
3.64%
|
Announcement Date
|
6/9/21
|
3/10/22
|
3/8/23
|
2/15/24
|
-
|
-
|
-
|
Last Close Price
2.774
EUR Average target price
3.348
EUR Spread / Average Target +20.71% Consensus |
1st Jan change
|
Capi.
|
---|
| +9.80% | 1.56B | | -14.81% | 75.25B | | +15.44% | 8.33B | | +26.62% | 3.77B | | -0.97% | 3.22B | | -10.58% | 1.47B | | -22.01% | 1.28B | | -8.49% | 1.21B | | -4.79% | 1.21B | | +7.99% | 1.15B |
Veterinary Drugs
|